Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02722174 · ClinicalTrials.gov registry record
Fingerprinting of Impulsivity
A clinical trial, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- 141
- Enrollment target
NCT02722174 is a clinical trial that has completed, run by Boehringer Ingelheim. The registered enrollment target is 141 participants.
The verdict
NCT02722174 has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- 141 participants
- Enrollment target
Study Summary
The study aims to examine a battery of behavioral and questionnaire measures in 4 disorders clinically associated with impulsivity and in health controls, to: 1) investigate if the different populations have a distinct behavioral profile, and 2) to investigate if there are specific measures that are reliable and sensitive measures of impulsivity across diagnoses.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2016-07-22 |
| Est. Completion | 2018-09-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02722174
The ClinicalTrials.gov registry entry for NCT02722174 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boehringer Ingelheim, which has 515 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02722174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02722174 about?
NCT02722174 is a clinical study titled "Fingerprinting of Impulsivity". The study aims to examine a battery of behavioral and questionnaire measures in 4 disorders clinically associated with impulsivity and in health controls, to: 1) investigate if the different populations have a distinct behavioral profile, and 2) to investigate if there are specific measures that are...
What is the current status of trial NCT02722174?
This trial is currently completed. The enrollment target is 141 participants. The study started on 2016-07-22. Estimated completion is 2018-09-06.
Who is sponsoring clinical trial NCT02722174?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.